Trial intelligence / Profile preview

Nebido in Elderly Men With Symptomatic Late Onset Hypogonadism

NCT00710827Phase 4Withdrawn

Sponsor
Bayer
Start
Oct 2008
Modality
Hormone, Biologic
Countries
6
01

Overview

A Phase 4 trial of testosterone undecanoate in Hypogonadism, sponsored by Bayer. Planned start Oct 2008; status: withdrawn.

02

Drugs

testosterone undecanoate
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT00710827.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00710827.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call